This cohort study assesses the prospective association of coronary artery calcification with risk of cardiovascular disease and all-cause mortality among dialysis-naive adult patients with chronic kidney disease from 7 US clinical centers.
This review synthesizes data on risk assessment for sudden cardiac death and sudden cardiac arrest from population studies that included large longitudinal and cross-sectional databases, observational cohort studies, and randomized clinical trials.
This community-based study compares the relative accuracy of US Preventive Services Task Force and American College of Cardiology/American Heart Association recommendations in identifying African American individuals with subclinical and clinical atherosclerotic cardiovascular disease.
This cohort study uses HCUP National Inpatient Sample data to assess the bleeding complications following endovascular procedures that use large-bore catheters and the association with in-hospital mortality risk, length of stay, and cost.
This Viewpoint discusses recent efforts to improve the low rates and quality of cardiopulmonary resuscitation (CPR) by bystanders in China via CPR training.
This nationwide cohort study examined changes in bystander defibrillation and subsequent survival among patients with out-of-hospital cardiac arrest according to public or residential location.
This randomized clinical trial assesses the prognosis of cardiovascular and bleeding events occurring beyond 1 year after coronary stenting.
An asymptomatic woman in her 30s with history of tetralogy of Fallot presented for evaluation of her congenital heart disease; on examination, venous pressure was visualized 4 cm above the clavicle at 45° with a prominent a wave. What would you do next?
This prespecified analysis assesses the safety and clinical efficacy of achieving a very low (<30 mg/dL) level of low-density lipoprotein cholesterol at 1 month in patients with acute coronary syndrome using data from the Improved Reduction of Outcomes: Vytorin Efficacy International Trial.
This observational extension of the OSLER-1 randomized clinical trial determines whether low-density lipoprotein cholesterol level reductions with evolocumab persist across different patient populations.
This Viewpoint discusses the potential effect of the US president’s executive order restricting travel from specific countries on the contributions of immigrant cardiologists working in the US health care system.
This multicenter study examines access to reperfusion and percutaneous coronary intervention during ST-segment elevation myocardial infarction in Indian clinics and hospitals using a hub-and-spoke model.
This secondary analysis of the EUROMAX randomized clinical trial assesses the effect of bivalirudin vs heparin plus optional glycoprotein IIb/IIIa inhibitors on 1-year mortality in patients with ST-segment elevation myocardial infarction.
This study assesses whether there is a time-dependent trend in microvascular damage in patients presenting with takotsubo cardiomyopathy by invasively measuring the index of microvascular resistance.
This Viewpoint argues for a reconfiguration of the transition phase between hospital and home by extending active treatment beyond the acute care setting.
This study examines trends in use of moderate-intensity and high-intensity statin in US cardiology practices before and after publication of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline.
This multicenter, randomized clinical trial investigates whether ischemic postconditioning of the infarct-related artery vs conventional percutaneous coronary intervention can improve the clinical outcomes of patients with acute onset of ST-segment elevation myocardial infarction.
This secondary analysis of a randomized clinical trial assesses whether a link exists between the length of procedure time and acute stent thrombosis in patients treated with bivalirudin vs heparin plus glycoprotein IIb/IIIa inhibitor.